Therefore, the current work aimed to evaluate the expression profiles of MALAT1 and miR-155, together with, the inflammatory markers; TNFα and IL-6, and the adhesion molecule, cluster of differentiation 106 (CD106), in BD patients. This evidence concerns the gene VCAM1 and Behcet disease.